Work

Pertuzumab : un nouvel agent dans la prise en charge du cancer du sein HER2 positif Données des études précliniques et cliniques Pertuzumab: a new agent in HER2-positive breast cancer Data from preclinical and clinical studies

Year: 2012

Type: article

Source: Journal de Pharmacie Clinique

DOI: 10.1684/jpc.2012.0206

Authors: Vincent Launay‐Vacher, Jean‐Philippe Spano, Jean‐Baptiste Rey

Language: French

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2097658072

FWCI:

Cites: 13

Cited by:

Related to: 10